Synlogic (SYBX) News Today → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free SYBX Stock Alerts $1.87 +0.01 (+0.54%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineSynlogic (NASDAQ:SYBX) Stock Passes Above 50 Day Moving Average of $1.82americanbankingnews.com - April 20 at 3:56 AMSynlogic, Inc. (SYBX)finance.yahoo.com - April 16 at 10:28 AMSynlogic's head of finance sells shares worth $325investing.com - April 6 at 2:07 PMHold Rating on Synlogic Amidst Lead Program Discontinuation and Strategic Uncertaintiesmarkets.businessinsider.com - March 21 at 10:42 AMSynlogic Reports Fourth Quarter and Full Year 2023 Financial Resultsglobenewswire.com - March 19 at 7:00 AMSynlogic Adopts Limited Duration Stockholders Rights Planfinance.yahoo.com - February 20 at 1:34 PMSynlogic Adopts Limited Duration Stockholders Rights Planglobenewswire.com - February 20 at 12:15 PMHold Rating on Synlogic Amid Discontinued Lead Program and Reduced Price Targetmarkets.businessinsider.com - February 13 at 7:53 PMSynlogic, Inc.: Synlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate Updatefinanznachrichten.de - February 9 at 7:31 PMSynlogic plunges as it ceases operations following decision to discontinue Synpheny-3 studyin.investing.com - February 9 at 2:30 PMSynlogic just downgraded at Chardan, here's whyrealmoney.thestreet.com - February 9 at 2:30 PMRare Disease Focused-Synlogic Pulls Plug On Lead Program, Shares Nosedivemsn.com - February 9 at 2:30 PMSynlogic cuts most workers after halting rare disease drug trialbizjournals.com - February 9 at 2:30 PMSynlogic shares crater amid company shut down, failed drug studymsn.com - February 9 at 2:30 PMWhy Is Synlogic (SYBX) Stock Down 55% Today?msn.com - February 9 at 9:29 AMWhy Is Synlogic (SYBX) Stock Down 55% Today?investorplace.com - February 9 at 8:42 AMSynlogic to Cease Operations, Cut Almost All Employees After Ending Trialmarketwatch.com - February 8 at 7:47 PMSynlogic Shares Tumble 55% on Discontinued Trial, Halt to Operationsmarketwatch.com - February 8 at 7:47 PMSynlogic to discontinue lead drug program, cease operationsmsn.com - February 8 at 7:47 PMSynlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate Updatefinance.yahoo.com - February 8 at 7:47 PMSynlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate Updatefinance.yahoo.com - February 8 at 7:47 PMmarketbeat.com - February 8 at 4:15 PMSynlogic Inc (MIN.MU)ca.finance.yahoo.com - February 6 at 9:18 PMSynlogic, Inc.: Synlogic Announces Publication of Preclinical and Clinical Data for SYNB1353 as a Potential Treatment for Classical Homocystinuriafinanznachrichten.de - February 3 at 3:36 PMSynlogic Announces Publication of Preclinical and Clinical Data for SYNB1353 as a Potential Treatment for Classical Homocystinuriafinance.yahoo.com - February 2 at 1:22 PMSynlogic Stock (NASDAQ:SYBX) Dividends: History, Yield and Datesbenzinga.com - January 17 at 8:59 AMAnalysts Offer Insights on Healthcare Companies: Fusion Pharmaceuticals (FUSN), Enanta Pharmaceuticals (ENTA) and Synlogic (SYBX)markets.businessinsider.com - January 9 at 8:07 PMOptimistic Outlook for Synlogic’s Growth Potential and Financial Sustainabilitymarkets.businessinsider.com - January 6 at 8:06 AMSynlogic, Inc.: Synlogic Provides Corporate Update and Outlook for 2024finanznachrichten.de - January 4 at 12:24 PMSynlogic provides corporate update, outlook for 2024msn.com - January 4 at 12:24 PMSynlogic Provides Corporate Update and Outlook for 2024finance.yahoo.com - January 4 at 7:23 AMSynlogic, Inc.: Synlogic Announces Contract with the Air Force Research Labfinanznachrichten.de - December 27 at 10:17 AMSynlogic bags contract to develop live probiotic productsmsn.com - December 27 at 10:17 AMSynlogic Secures $1 Mln Subcontract Under Air Force Research Labmarkets.businessinsider.com - December 27 at 10:17 AMSynlogic Announces Contract with the Air Force Research Labfinance.yahoo.com - December 27 at 10:17 AMSynlogic Stock (NASDAQ:SYBX), Analyst Ratings, Price Targets, Predictionsbenzinga.com - December 13 at 5:59 PMSynlogic Announces Abstract Accepted for Poster Presentation at the International Conference on Microbiome Engineering 2023finance.yahoo.com - December 7 at 10:04 AMProgressive Synpheny-3 Trial and Extended Patent Protection Propel Buy Rating for Synlogicmarkets.businessinsider.com - November 13 at 10:39 PMSynlogic’s Financial Strength and Promising Clinical Trials Bolster Buy Ratingmarkets.businessinsider.com - November 11 at 7:29 AMSynlogic: Q3 Earnings Insightsbenzinga.com - November 9 at 12:38 PMSynlogic Reports Third Quarter 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - November 9 at 7:38 AMSynlogic Inc (SYBX) Reports Q3 2023 Financial Results with Extended Cash Runway and Clinical ...finance.yahoo.com - November 9 at 7:38 AMSynlogic Achieves Research Milestone and Earns $2.5 Million Milestone Payment from Roche Collaborationfinance.yahoo.com - November 7 at 8:32 AMSynlogic, Inc. (SYBX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Releasefinance.yahoo.com - November 2 at 2:41 PMSynlogic Announces Closing of $21.0 Million Underwritten Public Offeringfinance.yahoo.com - October 3 at 7:03 PMSynlogic, Inc.: Synlogic Announces Pricing of $21.0 Million Underwritten Public Offeringfinanznachrichten.de - September 29 at 12:44 PMSynlogic Announces Pricing of $21.0 Million Underwritten Public Offeringfinance.yahoo.com - September 29 at 7:43 AMSynlogic Announces Publication of Synpheny-1 Phase 2 Study of Synthetic Biotic for Phenylketonuria in Nature Metabolismfinance.yahoo.com - September 28 at 3:20 PMmarketbeat.com - September 28 at 12:31 PMmarketbeat.com - September 28 at 11:34 AM Get Synlogic News Delivered to You Automatically Sign up to receive the latest news and ratings for SYBX and its competitors with MarketBeat's FREE daily newsletter. Email Address A new way to collect income from stocks (Ad)Most people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. SYBX Media Mentions By Week SYBX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SYBX News Sentiment▼0.720.33▲Average Medical News Sentiment SYBX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SYBX Articles This Week▼01▲SYBX Articles Average Week Get Synlogic News Delivered to You Automatically Sign up to receive the latest news and ratings for SYBX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Onconova Therapeutics News Today MEI Pharma News Today Lumos Pharma News Today Vincerx Pharma News Today Cumberland Pharmaceuticals News Today FSD Pharma News Today Biora Therapeutics News Today BioVie News Today Flora Growth News Today NeuroSense Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SYBX) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synlogic, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.